SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000870
Filing Date
2024-05-15
Accepted
2024-05-15 16:19:17
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20240331x10q.htm   iXBRL 10-Q 1095100
2 EX-10.1 eyen-20240331xex10d1.htm EX-10.1 84579
3 EX-31.1 eyen-20240331xex31d1.htm EX-31.1 14251
4 EX-31.2 eyen-20240331xex31d2.htm EX-31.2 14000
5 EX-32.1 eyen-20240331xex32d1.htm EX-32.1 8491
6 EX-32.2 eyen-20240331xex32d2.htm EX-32.2 8464
  Complete submission text file 0001410578-24-000870.txt   5778853

Data Files

Seq Description Document Type Size
7 EX-101.SCH eyen-20240331.xsd EX-101.SCH 51135
8 EX-101.CAL eyen-20240331_cal.xml EX-101.CAL 47218
9 EX-101.DEF eyen-20240331_def.xml EX-101.DEF 142532
10 EX-101.LAB eyen-20240331_lab.xml EX-101.LAB 352614
11 EX-101.PRE eyen-20240331_pre.xml EX-101.PRE 290237
70 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20240331x10q_htm.xml XML 991176
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 24951141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)